Clearasil Rapid Rescue Deep Treatment Pads Recalled for Label Error
RB Health (US) is recalling Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%) due to an incorrect label on the back of the packaging. The recall affects 36,426 individual units distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class III recall involves a minor labeling error regarding declared strength on the product packaging. No reported illnesses, injuries, or deaths are documented in the source material.
Plain-English summary
Clearasil Rapid Rescue Deep Treatment Pads, a topical acne treatment containing 2% salicylic acid, are being recalled by RB Health (US) LLC due to a labeling error on the back of the product packaging.
The back label of the affected packaging displays an incorrect declared strength designation. This labeling discrepancy may cause confusion about the actual strength of the product.
The recall affects 6,072 cases (36,426 individual selling units) distributed nationwide. The affected product is identified by Lot # KT220211 with an expiration date of 07/2024 (NDC 63824-431-90).
Consumers who have purchased this product should check the lot number and expiration date on their package. If you have the affected lot, contact RB Health (US) LLC or visit the FDA website for additional information about this recall.
The recalled product
- Product
- CLEARASIL RAPID RESCUE DEEP TREATMENT PADS (SALICYLIC ACID)
- Brand
- CLEARASIL RAPID RESCUE DEEP TREATMENT PADS
- Manufacturer
- RB Health (US) LLC
- Category
- Drug — Over-the-Counter Topical
- Hazard
- labeling-error
- strength-mislabeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # KT220211
- Exp 07/2024
UPCs (1)
- 0839977009200
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27